ZYDUS LIFESCIENCES
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Zydus Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.24₹ 12.2
As on Oct 1, 2025, 4:01 PM IST
Zydus Lifesciences Price Performance
Today's LowToday's High
₹981.80₹997.45
₹993.90
52 Weeks' Low52 Weeks' High
₹797.05₹1,087.80
₹993.90
Open Price
₹981.80
Prev. Close
₹981.70
Volume
6,235
Over the last 5 years, the share price of Zydus Lifesciences has gained 20.08% CAGR. Over the past year, the corresponding return has been -8.02%.
Zydus Lifesciences’s current P/E of 21.82x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Zydus Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | -3.99 | 0.33 | -0.75 | 13.26 | -8.02 | 34.41 | 20.08 |
| Sun Pharmaceutical Industries | 0.57 | 4.66 | -1.86 | -3.58 | -14.76 | 20.10 | 26.41 |
| Divi's Laboratories | -4.68 | -6.37 | -16.75 | 2.79 | 5.15 | 15.24 | 13.23 |
| Cipla | -1.78 | -4.86 | -0.36 | 4.57 | -9.20 | 10.13 | 14.33 |
| Torrent Pharmaceuticals | -1.10 | -0.17 | 4.66 | 12.38 | 6.09 | 31.30 | 20.48 |
| Dr. Reddy's Laboratories | -4.08 | -2.66 | -2.40 | 8.14 | -7.64 | 12.13 | 4.04 |
| Mankind Pharma | -3.43 | -3.03 | 6.72 | -0.57 | -5.20 | 19.71 | 11.40 |
| Lupin | -0.65 | 4.20 | 0.86 | 1.11 | -9.85 | 39.89 | 13.98 |
| Alkem Laboratories | -1.92 | 3.20 | 12.71 | 13.14 | -11.10 | 18.61 | 14.80 |
| Abbott India | -1.17 | -7.08 | -14.11 | -1.67 | 2.61 | 16.51 | 12.72 |
| Aurobindo Pharma | -0.40 | 6.00 | -4.01 | -4.21 | -24.43 | 26.64 | 5.83 |
| Glenmark Pharmaceuticals | -3.19 | 1.30 | 11.34 | 29.47 | 17.20 | 69.52 | 31.82 |
| Laurus Labs | -4.08 | 1.38 | 16.90 | 45.74 | 86.16 | 19.40 | 25.47 |
| Biocon | -3.40 | -1.67 | -4.33 | 2.21 | -6.41 | 5.89 | -5.19 |
| GlaxoSmithKline Pharmaceuticals | -1.80 | -3.77 | -19.48 | -3.39 | -1.45 | 24.00 | 11.49 |
| Anthem Biosciences | -5.95 | -5.20 | 5.77 | 5.77 | 5.77 | 1.89 | 1.13 |
| Ipca Laboratories | -1.82 | -2.92 | -3.35 | -4.82 | -11.04 | 12.36 | 3.36 |
| Cohance Lifesciences | -2.60 | -3.14 | -9.01 | -18.68 | -27.33 | 25.42 | 17.17 |
| Gland Pharma | -0.07 | 5.68 | 5.24 | 27.01 | 9.73 | -2.55 | 1.64 |
| Ajanta Pharma | -5.11 | -2.08 | -4.17 | -8.21 | -26.28 | 23.08 | 17.87 |
Over the last one year, Zydus Lifesciences has declined 8.02% compared to peers like Sun Pharmaceutical Industries (-14.76%), Divi's Laboratories (5.15%), Cipla (-9.20%). From a 5 year perspective, Zydus Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (26.41%) and Divi's Laboratories (13.23%).
Zydus Lifesciences Financials
Zydus Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,040.11 | 1,006.31 |
| 10 | 1,039.99 | 1,016.82 |
| 20 | 1,020.62 | 1,017.12 |
| 50 | 991.56 | 1,000.23 |
| 100 | 967.35 | 980.33 |
| 200 | 948.79 | 967.27 |
Zydus Lifesciences Share Holding Pattern
In the latest quarter, Zydus Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 11.13%, FII holding fell to 7.13%, and public shareholding moved up to 6.74% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Zydus Lifesciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 1,47,86,344 | 1.26 | 1,450.61 |
| Kotak Flexicap Fund - Regular Plan | 1,05,00,000 | 1.92 | 1,030.1 |
| ICICI Prudential Bluechip Fund | 42,77,967 | 0.58 | 419.69 |
| ICICI Prudential India Opportunities Fund | 22,80,577 | 0.75 | 223.74 |
| Nippon India Pharma Fund | 20,00,632 | 2.35 | 196.27 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 17,61,233 | 2.8 | 172.79 |
| ICICI Prudential Value Discovery Fund | 15,25,129 | 0.28 | 149.62 |
| ICICI Prudential Large & Mid Cap Fund | 10,56,117 | 0.44 | 103.61 |
| Sundaram Mid Cap Fund | 10,23,690 | 0.8 | 100.43 |
| ICICI Prudential Nifty Next 50 Index Fund | 8,39,499 | 1.08 | 82.36 |
Zydus Lifesciences Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Zydus Lifesciences Options
Zydus Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 30, 2025, 10:04 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Sep 25, 2025, 9:19 PM IST | Zydus Lifesciences - Receipt Of Order From Commissioner Of CGST, Ahmedabad |
| Sep 24, 2025, 4:04 PM IST | Zydus Lifesciences - Transcript Of The 30Th Annual General Meeting |
| Sep 23, 2025, 5:45 AM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 21, 2025, 2:16 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Zydus Lifesciences
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 15116.30 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressZydus Corporate Park, Scheme No.63, Survey No. 536, Ahmedabad Gujarat 382481
- Contact
Management
- Mr. Pankaj R PatelChairman
- Dr. Sharvil P PatelManaging Director
- Mr. Ganesh N NayakExecutive Director
- Mr. Mukesh M PatelNon Executive Director
- Mr. Bhadresh K ShahIndependent Director
- Ms. Apurva S DiwanjiIndependent Director
- Mr. Monappa Arun AkhilIndependent Director
- Mrs. Upasana K KonidelaIndependent Woman Director
- Ms. Shelina P ParikhIndependent Woman Director
FAQs on Zydus Lifesciences Share Price
What is the share price of Zydus Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Zydus Lifesciences is ₹993.90 as on Oct 01, 2025.
What kind of stock is Zydus Lifesciences?
The Zydus Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Zydus Lifesciences?
The market cap of Zydus Lifesciences is ₹100,009.60 Cr as on Oct 01, 2025.
What are today's High and Low prices of Zydus Lifesciences?
Today’s highest and lowest price of Zydus Lifesciences are ₹997.45 and ₹981.80.
What are the 52 Week High and 52 Week Low of Zydus Lifesciences?
The 52-week high/low is the highest and lowest price at which Zydus Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Zydus Lifesciences is ₹1,087.80 and 52-week low of Zydus Lifesciences is ₹797.05 as on Oct 01, 2025.
How has the Zydus Lifesciences performed historically in terms of returns?
The Zydus Lifesciences has shown returns of 1.24% over the past day, 0.33% for the past month, -0.75% over 3 months, -8.02% over 1 year, 34.41% across 3 years, and 20.08% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Zydus Lifesciences?
P/E ratio of and PB ratio of Zydus Lifesciences are 21.82 and 4.58 on Oct 01, 2025. While the company gives a dividend yield of 1.11 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data